U.S. flag

An official website of the United States government

NM_001040142.2(SCN2A):c.4025T>C (p.Leu1342Pro) AND Developmental and epileptic encephalopathy, 11

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Jan 21, 2019
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001252986.1

Allele description [Variation Report for NM_001040142.2(SCN2A):c.4025T>C (p.Leu1342Pro)]

NM_001040142.2(SCN2A):c.4025T>C (p.Leu1342Pro)

Gene:
SCN2A:sodium voltage-gated channel alpha subunit 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q24.3
Genomic location:
Preferred name:
NM_001040142.2(SCN2A):c.4025T>C (p.Leu1342Pro)
Other names:
p.L1342P:CTG>CCG
HGVS:
  • NC_000002.12:g.165374737T>C
  • NG_008143.1:g.140336T>C
  • NM_001040142.2:c.4025T>CMANE SELECT
  • NM_001040143.2:c.4025T>C
  • NM_001371246.1:c.4025T>C
  • NM_001371247.1:c.4025T>C
  • NM_021007.3:c.4025T>C
  • NP_001035232.1:p.Leu1342Pro
  • NP_001035233.1:p.Leu1342Pro
  • NP_001358175.1:p.Leu1342Pro
  • NP_001358176.1:p.Leu1342Pro
  • NP_066287.2:p.Leu1342Pro
  • NP_066287.2:p.Leu1342Pro
  • NC_000002.11:g.166231247T>C
  • NM_001040142.1:c.4025T>C
  • NM_021007.2:c.4025T>C
Protein change:
L1342P
Links:
dbSNP: rs796053134
NCBI 1000 Genomes Browser:
rs796053134
Molecular consequence:
  • NM_001040142.2:c.4025T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001040143.2:c.4025T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001371246.1:c.4025T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001371247.1:c.4025T>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_021007.3:c.4025T>C - missense variant - [Sequence Ontology: SO:0001583]
Functional consequence:
  • Effect on use dependence [Functional Epilepsy Nomenclature for Ion Channels: FENICS-0132]
  • Normal peak current [Functional Epilepsy Nomenclature for Ion Channels: FENICS-0096]
  • Normal slope of activation [Functional Epilepsy Nomenclature for Ion Channels: FENICS-0036]
  • Normal slope of fast inactivation [Functional Epilepsy Nomenclature for Ion Channels: FENICS-0074]
  • Overall mixed or unclear functional effect not able to be clearly categorized as Gain- or Loss-of-Function [Functional Epilepsy Nomenclature for Ion Channels: FENICS-0145]
  • Severe hyperpolarizing shift of voltage dependence of activation [Functional Epilepsy Nomenclature for Ion Channels: FENICS-0031]
  • Severe hyperpolarizing shift of voltage dependence of fast inactivation [Functional Epilepsy Nomenclature for Ion Channels: FENICS-0069]
  • Slowing of recovery from fast inactivation [Functional Epilepsy Nomenclature for Ion Channels: FENICS-0055]
Observations:
1

Condition(s)

Name:
Developmental and epileptic encephalopathy, 11 (DEE11)
Synonyms:
Early infantile epileptic encephalopathy 11
Identifiers:
MONDO: MONDO:0013388; MedGen: C3150987; Orphanet: 1934; OMIM: 613721

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001428474Institute of Human Genetics, University of Leipzig Medical Center
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Jan 21, 2019)
de novoclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedde novoyes1not providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Institute of Human Genetics, University of Leipzig Medical Center, SCV001428474.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testing PubMed (1)

Description

This variant was identified as de novo (maternity and paternity confirmed).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Mar 16, 2025